- Home
- PBYI vs RCMT Comparison
PBYI vs RCMT Comparison
Compare PBYI & RCMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- RCMT
- Stock Information
- Founded
- PBYI 2010
- RCMT 1971
- Country
- PBYI United States
- RCMT United States
- Employees
- PBYI N/A
- RCMT N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- RCMT Professional Services
- Sector
- PBYI Health Care
- RCMT Consumer Discretionary
- Exchange
- PBYI Nasdaq
- RCMT Nasdaq
- Market Cap
- PBYI 152.4M
- RCMT 133.5M
- IPO Year
- PBYI N/A
- RCMT N/A
- Fundamental
- Price
- PBYI $3.28
- RCMT $22.89
- Analyst Decision
- PBYI Strong Buy
- RCMT Strong Buy
- Analyst Count
- PBYI 1
- RCMT 2
- Target Price
- PBYI $7.00
- RCMT $33.50
- AVG Volume (30 Days)
- PBYI 375.3K
- RCMT 36.6K
- Earning Date
- PBYI 05-08-2025
- RCMT 05-07-2025
- Dividend Yield
- PBYI N/A
- RCMT N/A
- EPS Growth
- PBYI 143.51
- RCMT N/A
- EPS
- PBYI 0.77
- RCMT 1.74
- Revenue
- PBYI $232,709,000.00
- RCMT $290,914,000.00
- Revenue This Year
- PBYI N/A
- RCMT $16.29
- Revenue Next Year
- PBYI N/A
- RCMT $6.16
- P/E Ratio
- PBYI $4.25
- RCMT $13.19
- Revenue Growth
- PBYI 2.68
- RCMT 8.53
- 52 Week Low
- PBYI $2.23
- RCMT $13.18
- 52 Week High
- PBYI $4.13
- RCMT $26.37
- Technical
- Relative Strength Index (RSI)
- PBYI 52.36
- RCMT 69.07
- Support Level
- PBYI $3.14
- RCMT $22.10
- Resistance Level
- PBYI $3.45
- RCMT $23.49
- Average True Range (ATR)
- PBYI 0.19
- RCMT 0.91
- MACD
- PBYI 0.01
- RCMT -0.07
- Stochastic Oscillator
- PBYI 51.19
- RCMT 70.67
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About RCMT RCM Technologies Inc.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.